Suppr超能文献

志贺样毒素II B亚单位的表达与纯化

Expression and purification of Shiga-like toxin II B subunits.

作者信息

Acheson D W, De Breucker S A, Jacewicz M, Lincicome L L, Donohue-Rolfe A, Kane A V, Keusch G T

机构信息

Division of Geographic Medicine and Infectious Diseases, New England Medical Center, Boston, Massachusetts 02111.

出版信息

Infect Immun. 1995 Jan;63(1):301-8. doi: 10.1128/iai.63.1.301-308.1995.

Abstract

Shiga-like toxins (SLTs), which are produced by certain strains of Escherichia coli, are composed of enzymatically active A and B subunit multimers responsible for the toxin's binding. We have previously purified large amounts of the SLT-I B subunit by using a hyperexpression vector in Vibrio cholerae under the control of the trc promoter. In this study we examined various expression vectors to maximize yields of the SLT-II B subunit. The SLT-II B subunit has been expressed by using both the T7 promoter and the tac promoter in E. coli. When expressed from a plasmid containing the structural gene for SLT-II B deleted of the leader sequence, SLT-II B was able to form multimers when cross-linked, although SLT-II B production from this plasmid was unreproducible. SLT-II B expressed in all three systems appeared to form unstable multimers, which did not readily bind to a monoclonal antibody which preferentially recognizes B subunit multimers. SLT-II B expression was not increased by moving any of the plasmids into V. cholerae. Polyclonal antibodies raised to SLT-II B in rabbits recognized B subunit in SLT-II holotoxin yet were poorly neutralizing. SLT-II B was also expressed as a fusion protein with maltose-binding protein and could be cleaved from maltose-binding protein with factor Xa. Although the expression vectors were able to make large amounts of SLT-II B, as determined by Western blotting (immunoblotting), the levels of purified SLT-II B subunit were low compared with those obtained previously for SLT-I B subunit, probably because of instability of the multimeric SLT-II B subunit.

摘要

志贺样毒素(SLTs)由某些大肠杆菌菌株产生,由具有酶活性的A和B亚基多聚体组成,负责毒素的结合。我们之前通过在霍乱弧菌中使用受trc启动子控制的超表达载体大量纯化了SLT-I B亚基。在本研究中,我们检测了各种表达载体,以最大化SLT-II B亚基的产量。SLT-II B亚基已在大肠杆菌中使用T7启动子和tac启动子进行表达。当从含有缺失前导序列的SLT-II B结构基因的质粒表达时,SLT-II B交联后能够形成多聚体,尽管从该质粒产生的SLT-II B不可重复。在所有三种系统中表达的SLT-II B似乎形成不稳定的多聚体,不易与优先识别B亚基多聚体的单克隆抗体结合。将任何一种质粒转移到霍乱弧菌中,SLT-II B的表达均未增加。用兔抗SLT-II B产生的多克隆抗体可识别SLT-II全毒素中的B亚基,但中和能力较差。SLT-II B也作为与麦芽糖结合蛋白的融合蛋白进行表达,并可用因子Xa从麦芽糖结合蛋白上切割下来。尽管通过蛋白质印迹法(免疫印迹法)测定,表达载体能够产生大量的SLT-II B,但与之前获得的SLT-I B亚基相比,纯化的SLT-II B亚基水平较低,这可能是由于多聚体SLT-II B亚基的不稳定性所致。

相似文献

1

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验